Pulmonary Tuberculosis
📧 Sign up to get email alerts when something new happens for Pulmonary Tuberculosis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2023-06-09Clinical Trial Update: Study to Evaluate EBA, Safety and Tolerability of Carbapenems in Adults With Pulmonary Tuberculosis [Phase 2]
Phase 2 study evaluating efficacy, safety, and tolerability of carbapenems in adults with pulmonary tuberculosis has completed.
-
CLINICAL_TRIALS trial_result · 2023-06-01Clinical Trial Update: Phase 1 Clinical Trial of Single-Vial ID93 + GLA-SE in Healthy Adults [Phase 1]
Phase 1 trial evaluating a single-vial ID93 + GLA-SE vaccine in healthy adults completed with results posted.
-
CLINICAL_TRIALS trial_result · 2023-05-01Clinical Trial Update: PanACEA Sutezolid Dose-finding and Combination Evaluation [Phase 2]
Phase 2 trial evaluating dose-finding and combination strategies for sutezolid in pulmonary tuberculosis.
-
CLINICAL_TRIALS trial_result · 2023-04-27Clinical Trial Update: A Randomised Trial to Evaluate Toxicity and Efficacy of 1200mg and 1800mg Rifampicin for Pulmonary Tuberculosis [Phase 3]
Phase 3 randomized trial evaluating 1200 mg vs 1800 mg rifampicin for pulmonary tuberculosis has completed.
-
CLINICAL_TRIALS trial_result · 2022-12-20Clinical Trial Update: Using Biomarkers to Predict TB Treatment Duration [Phase 2]
Phase 2 trial evaluating biomarkers to predict duration of pulmonary tuberculosis treatment; study completed with results posted.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2022-08-16Clinical Trial Update: Study on Three Doses of an Inactivated COVID-19 Vaccine in Chinese Pulmonary Tuberculosis Patients [Phase 4]
Phase 4 trial update evaluating three doses of an inactivated COVID-19 vaccine in patients with pulmonary tuberculosis in China; current sta…
-
CLINICAL_TRIALS trial_result · 2022-08-10Clinical Trial Update: BTZ-043 - Multiple Ascending Dose (MAD) to Evaluate Safety, Tolerability and Early Bactericidal Activity (EBA) [Phase 1, Phase 2]
A Phase 1/2 study of BTZ-043 evaluated safety, tolerability, and early bactericidal activity in pulmonary tuberculosis.
-
CLINICAL_TRIALS trial_result · 2022-06-21Clinical Trial Update: Fermented Soybean Supplementation Among Active Pulmonary Tuberculosis Patients With Standard Therapy in Indonesia [NA]
A completed clinical trial evaluating fermented soybean supplementation in active pulmonary tuberculosis patients on standard therapy; resul…
-
CLINICAL_TRIALS trial_result · 2022-06-15Clinical Trial Update: Efficacy of HUEXC030 in Subjects With Pulmonary Tuberculosis [Phase 2, Phase 3]
Phase 2/3 clinical trial evaluating HUEXC030 for pulmonary tuberculosis has completed.
-
CLINICAL_TRIALS trial_result · 2021-09-20Clinical Trial Update: Early Bactericidal Activity Safety Pulmonary Tuberculosis Pyrifazimine (TBI-166) [Phase 2]
Phase 2 trial update on pyrifazimine (TBI-166) assessing early bactericidal activity and safety in sensitive pulmonary tuberculosis.
-
CLINICAL_TRIALS trial_result · 2021-05-14Clinical Trial Update: PRACTECAL-PKPD Sub Study [Phase 2, Phase 3]
Phase 2/3 trial update for the PRACTECAL-PKPD Sub Study investigating treatment regimens for drug-resistant tuberculosis.
-
CLINICAL_TRIALS trial_result · 2021-04-19Clinical Trial Update: Latency in Pulmonary Tuberculosis [Phase 3]
Phase 3 clinical trial update on latency in pulmonary tuberculosis; study completed.
-
CLINICAL_TRIALS trial_result · 2020-11-09Clinical Trial Update: Pilot Clinical Trial of PRS TB Regimen I - Phase II [Phase 4]
Phase IV pilot clinical trial update of the PRS TB regimen for pulmonary tuberculosis with positive sputum microscopy completed.
-
CLINICAL_TRIALS trial_result · 2020-08-07Clinical Trial Update: Rosuvastatin Evaluation as a Tuberculosis Treatment Adjunct [Phase 2]
A Phase 2 clinical trial evaluating rosuvastatin as an adjunct to standard therapy for pulmonary tuberculosis.
-
CLINICAL_TRIALS trial_result · 2020-07-24Clinical Trial Update: Treatment Shortening of Drug-Sensitive Pulmonary Tuberculosis Using High Dose Rifampicin (Hi-DoRi-3) [Phase 3]
Phase 3 clinical trial investigating high-dose rifampicin to shorten treatment for drug-sensitive pulmonary tuberculosis (Hi-DoRi-3).
-
CLINICAL_TRIALS trial_result · 2020-03-23Clinical Trial Update: Trial of Faropenem and Cefadroxil (in Combination With Amoxicillin/Clavulanic Acid and Standard TB Drugs) in Patients With Pulmonary Tuberculosis: Measurement of Early Bactericidal Activity and Effects on Novel Biomarkers [Phase 2]
Phase 2 trial assessing the combination of faropenem and cefadroxil with amoxicillin/clavulanic acid and standard TB drugs in pulmonary tube…
-
CLINICAL_TRIALS trial_result · 2020-02-13Clinical Trial Update: Optimization of the TB Treatment Regimen Cascade [Phase 3]
Phase 3 clinical trial update on optimizing the tuberculosis treatment regimen cascade; study completed with results posted in 2020.
-
CLINICAL_TRIALS trial_result · 2020-02-06Clinical Trial Update: A Phase II Clinical Study of LCB01-0371 to Evaluate the EBA, Safety and PK [Phase 2]
Phase II clinical study of LCB01-0371 evaluating efficacy, safety, and pharmacokinetics in pulmonary tuberculosis has completed.
-
CLINICAL_TRIALS trial_result · 2019-09-10Clinical Trial Update: A Phase 2 Study to Evaluate Early Bactericidal Activity, Safety, Tolerability, and Pharmacokinetics of Multiple Oral Doses of Telacebec (Q203) [Phase 2]
A Phase 2 study assessing early bactericidal activity, safety, tolerability, and PK of multiple oral doses of Telacebec (Q203) in treatment-…
-
CLINICAL_TRIALS trial_result · 2019-05-07Clinical Trial Update: Pharmacokinetics, Safety and Tolerability of Escalating Rifapentine Doses in Healthy Volunteers [Phase 1]
A Phase 1 trial assessing pharmacokinetics, safety, and tolerability of escalating rifapentine doses in healthy volunteers completed with po…
-
CLINICAL_TRIALS trial_result · 2019-04-10Clinical Trial Update: Comparing Daily vs Intermittent Regimen of ATT in HIV With Pulmonary Tuberculosis [Phase 3]
Phase 3 trial comparing daily versus intermittent regimen of ATT (anti-tuberculosis therapy) in patients with HIV and pulmonary tuberculosis…
-
CLINICAL_TRIALS trial_result · 2019-03-26Clinical Trial Update: Shortening Treatment by Advancing Novel Drugs [Phase 3]
Phase 3 trial update on shortening treatment by advancing novel drugs for pulmonary tuberculosis, including drug-sensitive and multi-drug-re…
-
CLINICAL_TRIALS trial_result · 2019-01-11Clinical Trial Update: A Phase 2 Trial to Evaluate the Efficacy and Safety of Linezolid in Tuberculosis Patients. (LIN-CL001) [Phase 2]
Phase 2 trial assessing the efficacy and safety of linezolid in patients with pulmonary tuberculosis has been completed.
-
CLINICAL_TRIALS trial_result · 2018-11-26Clinical Trial Update: Safety, Tolerability, Extended Early Bactericidal Activity and PK of Higher Doses Rifampicin in Adults With Pulmonary TB [Phase 2]
A Phase 2 clinical trial evaluating safety, tolerability, extended early bactericidal activity, and pharmacokinetics of higher rifampicin do…
-
CLINICAL_TRIALS trial_result · 2018-11-09Clinical Trial Update: Phase 2a ID93 + GLA-SE Vaccine Trial in TB Patients After Treatment Completion [Phase 2]
Phase 2a trial of ID93 + GLA-SE vaccine in adults with pulmonary tuberculosis completed; results posted in 2018.